Sign in

Professor Georgina V Long AO

@gvlongphdmd.bsky.social
146 followers 25 following 10 posts

Medical Oncologist & Immunotherapist, Clinical Trialist, Cancer Drug Developer, Translational Researcher University of Sydney, Medical Director Melanoma Institute Australia, Joint Australian of Year 2024, Fulbright Alumnus, Fellow AAS & AAHMS

PostsRepliesMedia
Professor Georgina V Long AO @gvlongphdmd.bsky.social · 29/10/2025
Join me & MIA multidisciplinary experts at Neoadjuvant Treatment Symposium, to help clinicians navigate the evolving treatment landscape for #melanoma, after recent PBS listing for #neoadjuvant regimens. Mon evening 24 Nov AEDT in person in Sydney, or online. events.humanitix.com/neoadjuvant-...
events.humanitix.com
Neoadjuvant treatment in 2025
Advance your expertise in neoadjuvant therapy and melanoma care at our upcoming symposium for multidisciplinary specialists.
020
Professor Georgina V Long AO @gvlongphdmd.bsky.social · 12/07/2025
INNOVATE Naples - Paolo Ascierto hosts clinician/researchers discussing #CANCER #NEOADJUVANT #immunotherapy. Favorite meeting for patient-centered novel trials. Discussed optimising immunotherapy across multiple cancers & #melanoma to cure more Grazie tutti!
031
Professor Georgina V Long AO @gvlongphdmd.bsky.social · 09/03/2025
Important week - #UnitedNation international #women’s day week! Honoured to speak about courage, unconscious bias, inspiration, and my 5 best pieces advice 4 action & change. #ING #marieclaire #NSWeducation #RoyalSocietyNSW @sydneyuni.bsky.social @melanomaau.bsky.social
170
Professor Georgina V Long AO @gvlongphdmd.bsky.social · 28/02/2025
This #science exciting! Collaborate, #clincaltrials, nurses, scientists - my co-lead H Rizos🤩. #immunotherapy 4 #GBM #glioblastoma Handed draft trial design+drugs to @jimwhittle.bsky.social @braincancercentre.bsky.social @sydneyuni.bsky.social @melanomaau.bsky.social www.nature.com/articles/s41...
nature.com
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma - Nature Medicine
A patient with newly diagnosed glioblastoma was safely treated with neoadjuvant nivolumab, relatlimab and ipilimumab before maximal resection, with comprehensive immune profiling showing the induction...
094
Professor Georgina V Long AO @gvlongphdmd.bsky.social · 28/02/2025
www.smh.com.au/national/can... @sydneyuni.bsky.social @wehi-research.bsky.social @jimwhittle.bsky.social @braincancercentre.bsky.social @melanomaau.bsky.social @science.org.au @ascocancer.bsky.social @ascopost.bsky.social @sitcancer.bsky.social
smh.com.au
Can this melanoma therapy beat brain cancer? We’re about to find out
A world-first clinical trial will investigate whether the experimental treatment given to a former Australian of the Year can treat aggressive tumours in other patients.
051
Professor Georgina V Long AO @gvlongphdmd.bsky.social · 18/02/2025
So proud of this aussie trial - changed practice. @melanomaau.bsky.social @sydneyuni.bsky.social @science.org.au Ipilimumab + nivolumab vs nivolumab in patients with #melanoma brain metastases (ABC): 7-yr follow-up of randomised, ph 2 study - The Lancet Oncology www.thelancet.com/journals/lan...
thelancet.com
Ipilimumab plus nivolumab versus nivolumab alone in patients with melanoma brain metastases (ABC): 7-year follow-up of a multicentre, open-label, randomised, phase 2 study
Our findings suggest that ipilimumab plus nivolumab maintains efficacy to at least 7 years in patients with active asymptomatic brain metastasis. Upfront ipilimumab plus nivolumab should be the standa...
0115
Professor Georgina V Long AO @gvlongphdmd.bsky.social · 08/02/2025
Welcome ‘25 @melanomaau.bsky.social fellows. Ciao fab Drs fr 2024 Ruby, Bec & Andea, work with top #clinicaltrials team & advance practice #nurses. Togeth we deliver #cancer care, keep patients SAFE & push boundaries - 0 deaths fr #melanoma. ❤️ Working to make a difference-Highlight of my work week.
010
Professor Georgina V Long AO @gvlongphdmd.bsky.social · 01/02/2025
Celebrating #australianoftheyear 2025 with my kids (1 in USA), my rock of a husband&my wise Mum. Lost Dad in 2024 ❤️ but made pioneering #melanoma research & transformed clinical practice, groundbreaking science with brilliant women, exploring Australia & #changemakers. youtu.be/VfJKuE114Do?...
Australian of the Year 2025Governor General of Australia, Sam Mostyn and Australian of the Year Alumni and Australian of the Year 2025 nomineesPrime Minister Anthony Albanese (second from right) and my Mum Ann Long, Richard Harris and Me - Georgina LongAustralian War Memorial
061
Professor Georgina V Long AO @gvlongphdmd.bsky.social · 29/01/2025
What an amazing group of 2025 Australians of the Year! Tears flowed freely as their stories were told - Neale #fightnmd, Olly #wheelchairs for kids, Katrina #QUT and Vanessa & Hannah #cafesteppingstone. Making #Australia a better place! @sydneyuni.bsky.social @melanomaau.bsky.social #AOTY
000
Professor Georgina V Long AO @gvlongphdmd.bsky.social · 04/01/2025
Looking fwd to 2025 - #clinicaltrials to cure #cancer & #melanoma, & #immunotherapy. My 2024 highlights: www.nejm.org/doi/abs/10.1... www.nejm.org/doi/full/10.... www.annalsofoncology.org/article/S092... ascopubs.org/doi/10.1200/... ascopubs.org/doi/10.1200/... www.nature.com/articles/s41...
nejm.org
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma | NEJM
In phase 1–2 trials in patients with resectable, macroscopic stage III melanoma, neoadjuvant immunotherapy was more efficacious than adjuvant immunotherapy. In this phase 3 trial, we randomly assig...
072